Home › Trial NCT01112384
A Study of SB939 in Patients With Translocation-Associated Recurrent/Metastatic Sarcomas
- Trial IDNCT01112384
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorNCIC Clinical Trials Group
- Enrollment24
- Start date2010-10-21
- ConditionsMetastatic Sarcoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.